Renovaro entered into a binding agreement merger agreement with Predictive Oncology, Inc. (“POI”) dated January 1, 2025, and supplemented with the Extension Agreement dated February 28, 2025 ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

Researchers engineered Shewanella oneidensis to produce extracellular DNA hydrogels, enabling the development of biohybrid materials for use in energy, biotechnology, and regenerative systems.

Expanded leadership team as eXoZymes ramps up commercial growthDamien Perriman brings more than two decades of experience in successfully ...

The interplay between aging and cellular senescence reveals insights into chronic inflammation and potential strategies for enhancing healthspan and longevity.

Those natural essential oils you love in your skincare? More than 90% of a plant is typically discarded during the oil ...

A Portuguese study found that over half of paracetamol-based painkillers and a quarter of ibuprofen liquids contain gluten or ...

PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs ...

The global High Content Screening Market , valued at US$1.47 billion in 2024, is forecasted to grow at a robust CAGR of 7.5%, reaching US$1.52 billion in 2025 and an impressive US$2.19 billion by 2030 ...

Several studies have reported that the coronavirus disease 2019 (COVID-19) can lead to heart rate variability (HRV), with the ...

Sucralose increases hypothalamic activity linked to hunger more than sugar or water, especially in women and people with ...